Table 1.
Relationship between CD4+ iTILs and clinicopathological factors
| Clinical pathological factors | CD4+ iTILs | P value | ||
|---|---|---|---|---|
|
| ||||
| Low | High | |||
| Gender | Male | 30 | 27 | 0.351 |
| Female | 14 (31.8%) | 19 (41.3%) | ||
| Age | ≤ 60 years | 19 | 23 | 0.517 |
| > 60 years | 25 (58.8%) | 23 (50%) | ||
| Pathologic differentiation | High | 27 | 32 | 0.413 |
| Low | 17 (38.6%) | 14 (30.4%) | ||
| Tumor size | ≤ 4 cm | 24 | 27 | 0.691 |
| > 4 cm | 20 (45.5%) | 19 (41.3%) | ||
| Nerve invasion | Negative | 24 | 29 | 0.413 |
| Positive | 20 (45.5%) | 17 (37.0%) | ||
| Lymphatic vessel invasion | Negative | 27 | 30 | 0.705 |
| Positive | 17 (38.6%) | 16 (34.8%) | ||
| Stage (I + II vs II + IV) | I | 13 | 27 | 0.005 |
| II + IV | 31 (70.5%) | 19 (41.3%) | ||